In-Person Meeting Taking Place in Orlando, Florida, May 13–15, 2021
WOLF CREEK, MT / ACCESSWIRE / May 3, 2021 / SOLO-DEX, the technology leader, developer and distributor of medical catheters, announces that its CEO, Steven C. Eror will participate in person at the 46th Annual Regional Anesthesiology and Acute Pain Medicine Meeting to be held in Orlando, Florida, from May 13-15, 2021. The American Society of Regional Anesthesia and Pain Medicine (ASRA) is one of the largest subspecialty medical societies in anesthesiology with more than 5,000 members in 66 countries on 6 continents.
Mr. Eror will be on-hand to showcase SOLO-DEX’s Facile® continuous peripheral nerve block – a cPNB catheter for managing pain before, during and after surgery. It places with industry-leading smoothness and accuracy and establishes the facile continuous nerve block catheter quickly and safely for common procedures like shoulder repair, hip and knee replacement and other general surgical procedures.
The use of regional anesthesia has grown in recent months as medical professionals try to minimize the manipulation of the patient’s airway, which can increase the risk of exposure to Covid-19 in the operating room. In addition, patients report the need for opioids is drastically reduced, and often, they are entirely unnecessary for pain management.
Mr. Eror said, “The twin difficulties of Covid-19 and opioid addiction disorder have made the physicians rely upon regional anesthesia to a degree we would not have imagined before the pandemic and the opioid crisis. Our heavily patented Facile® continuous peripheral nerve block makes their jobs easier by offering ease, accuracy and smoothness unavailable in any other nerve block catheter. I am looking forward to providing evaluation resources to qualified physicians at the ASRA meeting in Orlando.”
Conference participants or other medical professionals participating remotely, who are interested in one-on-one meetings with Steven C. Eror during the conference, please reach out to steve.eror@solo-dex.com or texting 801.631-7288 with the code ASRA.”
ABOUT SOLO-DEX
SOLO-DEX is the technology leader, developer and distributor of medical catheter, founded by leading anesthesiologists to reduce the cost and risk associated with general anesthesia by improving surgical patient recovery times, reducing medical personnel exposure to covid-19, reducing or eliminating the misuse of opioid-related pain management, and by safely and effectively managing pain before, during and after a procedure. For more information about SOLO-DEX, please log on to www.solo-dex.com
About ASRA
Our mission is to advance the science and practice of regional anesthesia and pain medicine to improve patient outcomes through research, education, and advocacy. The American Society of Regional Anesthesia and Pain Medicine (ASRA) is one of the largest subspecialty medical societies in anesthesiology with more than 5,000 members in 66 countries on 6 continents. We accomplish our mission and vision by addressing the clinical and professional educational needs of physicians and scientists, ensuring excellence in patient care utilizing regional anesthesia and pain medicine, and investigating the scientific basis of the specialty. Please log on to https://www.asra.com/
Media Contact:
Janet Vasquez, Public Relations
SOLO-DEX Inc.
pr@solo-dex.com
SOURCE: SOLO-DEX Inc.
View source version on accesswire.com:
https://www.accesswire.com/643658/SOLO-DEXs-CEO-Steven-C-Eror-Participating-in-46th-Annual-Regional-Anesthesiology-and-Acute-Pain-Medicine-Meeting
MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…
TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…
mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…
Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…
Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…